FOXO3 and hepatocellular carcinoma: Moreover, our published study indicated that SPR could promote hepatocellular carcinoma progression via FoxO3a/Bim signalling in a non‐enzymatic manner, while its enzymatic activity might have no effect on hepatocellular carcinoma development.44